Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Temocapril

Known as: (2S-(2alpha,6beta(R*)))-6-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)tetrahydro-5-oxo-2-(2-thienyl)-1,4-thiazepine-4(5H)-acetic Acid, Temocaprilum 
National Institutes of Health

Related topics

Related topics

1 relation
temocapril hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Species difference of esterase expression and hydrolase activity in plasma.
Differences in esterase expression among human, rhesus monkey, cynomolgus monkey, dog, minipig, rabbit, rat, and mouse plasma… 
Highly Cited
2006
Highly Cited
2006
Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril
Recent reports have shown that genetic polymorphisms in organic anion transporting polypeptide (OATP) 1B1 have an effect on the… 
Highly Cited
2006
Highly Cited
2006
Aldosterone breakthrough during therapy with angiotensin‐converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy
Background:  We are investigating whether aldosterone breakthrough negatively impacts on the antiproteinuric effects of… 
Highly Cited
2004
Highly Cited
2004
Blockade of the renin–angiotensin system decreases adipocyte size with improvement in insulin sensitivity
Objective Based on results of in vitro studies, it has been hypothesized that blockade of the renin–angiotensin system (RAS… 
Highly Cited
2004
Highly Cited
2004
Asymmetric Dimethylarginine Produces Vascular Lesions in Endothelial Nitric Oxide Synthase–Deficient Mice: Involvement of Renin-Angiotensin System and Oxidative Stress
Objective—Asymmetric dimethylarginine (ADMA) is widely believed to be an endogenous nitric oxide synthase (eNOS) inhibitor… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Highly Cited
2003
Highly Cited
2003
Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension
Abstract—Adiponectin, an adipocyte-derived protein, has been suggested to play an important role in insulin sensitivity. We… 
  • table 1
  • table 2
Highly Cited
2002
Highly Cited
2002
ACE Inhibitor Improves Insulin Resistance in Diabetic Mouse Via Bradykinin and NO
Improvement of insulin resistance by ACE inhibitors has been suggested; however, this mechanism has not been proved. We… 
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
Potential contribution of a novel antifibrotic factor, hepatocyte growth factor, to prevention of myocardial fibrosis by angiotensin II blockade in cardiomyopathic hamsters.
BACKGROUND Because hepatocyte growth factor (HGF) prevented and/or regressed fibrosis in liver and pulmonary injury models, HGF… 
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Highly Cited
1997
Highly Cited
1997
Converting enzyme inhibitor improves forearm reactive hyperemia in essential hypertension.
Endothelial function is known to be impaired in essential hypertensive patients. In this study, we examined whether… 
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
1997
Highly Cited
1997
Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis.
We have shown previously that angiotensin-converting enzyme (ACE) inhibitors prevent coronary vascular remodeling (medial… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE